Long-Term Risks of Anal Intercourse in Women
Yes, anal intercourse in women carries significant long-term health risks, most notably an increased risk of HPV-related anal cancer, sexually transmitted infections, and HIV transmission—with anal intercourse conferring substantially higher HIV transmission risk than vaginal intercourse.
Primary Long-Term Risk: Anal Cancer
The most serious long-term consequence is increased risk of anal squamous cell carcinoma (SCCA), which is strongly linked to persistent HPV infection 1. Women with a history of anal intercourse are specifically identified as a high-risk population for anal cancer screening programs 1.
Cancer Risk Context:
- HPV infection (particularly types 16 and 18) causes 80-85% of anal cancers 1
- Women with previous HPV-related gynecologic dysplasia and cancer have substantially elevated anal cancer incidence: 6-63 cases per 100,000 person-years (compared to 1-2 cases per 100,000 in the general population) 2
- Women with HIV infection face even higher risk: 20-30 cases per 100,000 person-years 2
- Anal cancer incidence is increasing globally in Europe, Australia, and the United States 1
Important Clinical Implication:
Female patients with anal intraepithelial neoplasia (AIN) should be screened for synchronous cervical, vulvar, and vaginal intraepithelial neoplasia 1, as HPV is a multifocal infection affecting multiple anatomic sites.
HIV and STI Transmission Risks
HIV Transmission:
Anal intercourse carries significantly greater HIV transmission efficiency than vaginal intercourse 3, 4. Studies consistently identify anal intercourse as a highly predictive risk factor for HIV seroconversion in heterosexual transmission 3.
Critical finding: In terms of absolute numbers, approximately seven times more women than homosexual men engage in unprotected receptive anal intercourse 3, yet prevention messaging for heterosexuals rarely emphasizes this route of transmission.
STI Risks:
Women who engage in unprotected anal intercourse are:
- 2.6 times more likely to report STD diagnosis compared to women with only unprotected vaginal intercourse 5
- 4.2 times more likely to report STD diagnosis compared to women with neither unprotected anal nor vaginal intercourse 5
- At risk for anorectal STDs, Hepatitis B infection, and HPV-related anal cancer 3
Prevalence and Condom Use Patterns
Understanding the scope of this practice is essential:
- 31-44% of women report anal intercourse at some point 6, 7
- Among women engaging in anal intercourse, condom use rates are nearly universally lower for anal than vaginal intercourse 3
- When anal intercourse occurs, it is commonly condomless: reported at 76% of visits among HIV-negative women and 51% among women with HIV 7
Associated Risk Factors
Women reporting anal intercourse are more likely to have experienced 7:
- Physical and/or sexual violence (aOR = 1.35-1.77)
- Excessive alcohol use (aOR = 1.27)
- Drug use (aOR = 1.34)
- Multiple male partners (aOR = 2.64)
- Exchange sex (aOR = 3.45)
- High depressive symptoms (aOR = 1.23)
These contextual factors indicate that anal intercourse often occurs in settings of vulnerability, violence, and substance use, complicating risk reduction efforts.
Screening Recommendations
Current guidelines from CDC and ESMO state:
- Data are insufficient to recommend routine anal cancer screening with anal cytology in the general population 2
- However, annual digital anorectal examination (DARE) may be useful in high-risk populations, including those with history of receptive anal intercourse 2
- Screening programs using anal cytology and high-resolution anoscopy have been proposed for HIV-negative women with history of anal intercourse or other HPV-related anogenital malignancies, but no randomized controlled study has demonstrated preventive benefit 1
Clinical Practice Implications
Critical Gap in Care:
Most healthcare providers fail to ask about anal intercourse when addressing safer sex in heterosexual populations 8, despite its prevalence and risks. This represents a significant missed opportunity for risk assessment and counseling.
What to Ask:
Standard questions about "anal intercourse" may miss women engaging in other anal-related sexual practices (anal fingering, oral-anal contact) that also carry HPV transmission risk 9. Adding detailed questions about anal-related sexual practices identifies an additional 5% of women with high-risk behaviors 9.
Counseling Priorities:
- Emphasize that anal intercourse carries higher HIV and STI transmission risk than vaginal intercourse
- Promote consistent condom use specifically for anal intercourse
- Screen for violence, substance use, and coercive sexual contexts
- Consider HPV vaccination status
- Discuss the long-term cancer risk associated with persistent HPV infection
Common Pitfalls to Avoid
- Assuming heterosexual women don't engage in anal intercourse due to cultural taboos—prevalence data clearly refute this
- Failing to screen for anal intercourse history when evaluating STI risk or providing sexual health counseling
- Not recognizing the connection between HPV-related gynecologic disease and anal cancer risk—these women need heightened awareness and possibly digital anorectal examination
- Overlooking the context of violence and substance use that frequently accompanies anal intercourse in high-risk populations
The evidence clearly demonstrates that anal intercourse in women carries substantial long-term health risks that are currently underaddressed in clinical practice and prevention messaging.